
|Articles|August 7, 2015
FDA Warning on MS Drug Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
A look back at the top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/fda-warning-on" target="_blank">View the story "FDA Warning on MS Drug Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
Managing Safety and Supportive Care With Pluvicto: Insights From the PSMAddition Trial
3
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
4
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
5

















































































































































































































